Sleep Disorders of Patients With Diseases of the Nervous System

Back to results

Primary Purpose

Status

Completed

Phase

Locations

United States

Study Type

Observational

Intervention

About this trial

This is an observational trial for Hypersomnia focused on measuring Narcolepsy, Polysomnography, Multiple Sleep Latency Test, Sleep Disorders, Hypersomnia, Periodic Leg Movements

Eligibility Criteria

5 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

IINCLUSION CRITERIA: Patients 5 years of age and older, with the following referring diagnoses: Narcolepsy Hypersomnia REM behavior disorder Frontal nocturnal dystonia Restless legs syndrome Insomnia Parasomnia Nocturnal epileptic seizure Nocturnal movement disorder Sleep-related diagnostic dilemma Sleep apnea associated with neurological disorders Patients who are ambulatory and who are able to comply with the study procedures. Patients who are able to understand and sign the informed consent. (Parent or guardian for minors). EXCLUSION CRITERIA: Patients who have been diagnosed with acute and progressive neurological disorders. Patients who are unable to comply with the study procedures and require other than standard care.

Sites / Locations

National Institutes of Health Clinical Center, 9000 Rockville Pike

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

NCT ID

NCT00001664

First Posted

November 3, 1999

Last Updated

June 30, 2017

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

1. Study Identification

Unique Protocol Identification Number

NCT00001664

Brief Title

Sleep Disorders of Patients With Diseases of the Nervous System

Official Title

Training Protocol for Various Sleep Disorders in Patients With Neurological Disorders

Study Type

Observational

2. Study Status

Record Verification Date

September 7, 2011

Overall Recruitment Status

Completed

Study Start Date

December 4, 1996 (undefined)

Primary Completion Date

undefined (undefined)

Study Completion Date

September 7, 2011 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

4. Oversight

5. Study Description

Brief Summary

The purpose of this study is to assist training doctors about different diseases of the nervous system affecting sleep. Patients selected to participate in this study will have any of a variety of sleep disorders. They will undergo several tests including an overnight recording of brain activity, eye movement, leg movement, breathing, heart rate, and other measures. Results of these tests will be used to better understand diseases causing sleep disorders and may be used to develop better treatments for them.

Detailed Description

The objective of this protocol is to provide training in a broad range of neurological sleep disorders to clinical associates who are eligible for sitting in the Board examination of the Added Qualification of Clinical Neurophysiology administered by the American Board of Psychiatry and Neurology. This protocol is to supplement small accrual of research patients who are referred from within the NIH.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Hypersomnia, Narcolepsy, Nervous System Disease, Sleep Disorder

Keywords

Narcolepsy, Polysomnography, Multiple Sleep Latency Test, Sleep Disorders, Hypersomnia, Periodic Leg Movements

7. Study Design

Enrollment

83 (Actual)

10. Eligibility

Sex

All

Minimum Age & Unit of Time

5 Years

Accepts Healthy Volunteers

No

Eligibility Criteria

IINCLUSION CRITERIA: Patients 5 years of age and older, with the following referring diagnoses: Narcolepsy Hypersomnia REM behavior disorder Frontal nocturnal dystonia Restless legs syndrome Insomnia Parasomnia Nocturnal epileptic seizure Nocturnal movement disorder Sleep-related diagnostic dilemma Sleep apnea associated with neurological disorders Patients who are ambulatory and who are able to comply with the study procedures. Patients who are able to understand and sign the informed consent. (Parent or guardian for minors). EXCLUSION CRITERIA: Patients who have been diagnosed with acute and progressive neurological disorders. Patients who are unable to comply with the study procedures and require other than standard care.

Facility Information:

Facility Name

National Institutes of Health Clinical Center, 9000 Rockville Pike

City

Bethesda

State/Province

Maryland

ZIP/Postal Code

20892

Country

United States

Hypersomnia, Narcolepsy, Nervous System Disease

About this trial

Eligibility Criteria

Sites / Locations

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial